| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |